Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Gene transfer methods

a gene transfer and gene technology, applied in the field of gene transfer methods, can solve the problems of unsatisfactory practical clinical application of gene transfer efficiency using a retrovirus, contaminated retrovirus-producer cells, and high labor intensity of virus-producer cells, and achieve the effect of enhancing the gene transfer efficiency of laminin

Inactive Publication Date: 2004-03-25
TAKARA HOLDINGS
View PDF6 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0012] In view of the circumstances as described above, the main object of the present invention is to provide an improved method for transferring a gene into target cells using a retrovirus, in which the gene transfer efficiency is increased and the target cells are efficiently transduced. Hereinafter, other objects and advantages of the present invention will be explained in detail with reference to the attached drawings.

Problems solved by technology

However, the retrovirus-producer cells may be contaminated in the gene transferred target cells which will be transplanted to a living body in this method.
However, the gene transfer efficiency using a retrovirus is still unsatisfactory for practical clinical application.
However, construction and establishment of virus-producer cells that can produce high titer viruses usually requires much labor.
However, since such concentration can be used only for this vector, it can not be widely used.
However, no convenient and efficient method is known in the current state of the art.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gene transfer methods
  • Gene transfer methods
  • Gene transfer methods

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0078] Preparation of Polypeptides derived from Fibronectin

[0079] A polypeptide derived from human fibronectin, H-271, was prepared from Escherichia coli HB101 / pHD101 (FERM BP-2264) containing a recombinant plasmid pHD101 which contains a DNA encoding the polypeptide according to the method as described in U.S. Pat. No. 5,198,423.

[0080] A polypeptide derived from human fibronectin, H-296, was prepared from Escherichia coli HB101 / pHD102 (FERM P-10721) containing a recombinant plasmid pHD102 which contains a DNA encoding the polypeptide according to the method as described in the above-mentioned publication.

[0081] A polypeptide CH-271 was prepared as follows.

[0082] Briefly, Escherichia coli HB101 / pCH101 (FERM BP-2799) was cultured according to the method as described in the above-mentioned publication. CH-271 was obtained from the culture.

[0083] A polypeptide CH-296 was prepared as follows.

[0084] Briefly, Escherichia coli HB101 / pCH102 (FERM BP-2800) was cultured according to the metho...

example 2

[0088] Construction of Retrovirus Vector and Preparation of Retrovirus Supernatant

[0089] A retrovirus plasmid, PM5neo vector, which contains a neomycin phosphotransferase gene [Exp. Hematol., 23:630-638 (1995)] was introduced into GP+E-86 cells (ATCC CRL-9642). The cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM; Bio Whittaker) containing 10% fetal calf serum (FCS; Gibco), 50 units / ml of penicillin and 50 .mu.g / ml of streptomycin (both from Gibco). All of the DMEMs used in the procedure hereinbelow contained the above-mentioned antibiotics. A supernatant containing PM5neo virus was prepared by adding 4 ml of DMEM containing 10% FCS to a plate (a 10-cm gelatin-coated dish for cell culture, Iwaki Glass) in which the above-mentioned producer cells had been grown to semi-confluence, culturing overnight and then collecting the supernatant. The thus collected culture supernatant was filtrated through a 0.45-micron filter (Millipore) to prepare a virus supernatant stock, wh...

example 3

[0093] Preparation of Functional Substance having Activity of Binding to Retrovirus and Measurement of Activity thereof

[0094] 50 .mu.l of 80 .mu.g / ml solution of H-271, H-296, C-274, CH-271, CH-296, ColV, human basic fibroblast growth factor (bFGF; Progen), tenascin (Gibco) or epidermal growth factor (EGF; Takara Shuzo), or 50 .mu.l of 2% bovine serum albumin (BSA, Sigma) was added to each well of a 96-well non-treated microplate for cell culture (Falcon). The plate was allowed to stand at 4 C. overnight and then washed twice with phosphate buffered saline (PBS; Roman Kogyo). Alternatively, after the plate was treated as described above, 0.1 ml of 4 mg / ml solution of 1-ethyl-3-dimethylaminopropylcarbodiimide hydrochloride (Sigma) in sterile pure water was dispensed to each well. The reaction was allowed to proceed at 37 C. for 2 hours. The plate was washed extensively with pure water to prepare a carbodiimide-treated plate. These plates were stored at 4 C. until viral infection expe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
pHaaaaaaaaaa
emission wavelengthaaaaaaaaaa
Login to View More

Abstract

Improved methods for transferring a gene into target cells by using a retrovirus, wherein the gene transfer efficiency is improved and the target cells are efficiently transformed by binding the retrovirus to a functional substance which is immobilized on as carrier and having an activity of binding to retroviruses followed by washing; using an antibody capable of specifically recognizing cells, laminin or mannose-rich type sugar chain as a substance having an activity of binding to the target cells; pre-treating the target cells so as to inactivate transferrin receptor, or introducing a new functional group into the functional substance.

Description

[0001] This is a division of copending parent application Ser. No. 09 / 743,354, which is the national stage under 35 USC 371 of the international application PCT / JP99 / 03403, filed Jun. 25, 1999.[0002] The present invention relates to a method that increases the efficiency of gene transfer into target cells and enables efficient transduction of the target cells, as well as a series of related techniques therewith, in the fields of medicine, cell technology, genetic engineering, developmental technology and the like.[0003] Mechanisms of a number of human diseases have been elucidated. The recombinant DNA techniques and the techniques for transferring a gene into cells have rapidly progressed. Under these circumstances, protocols for somatic gene therapies for treating severe genetic diseases have been recently developed. More recently, attempts have been made to apply the gene therapy not only to treatment of the genetic diseases but also to treatment of viral infections such as AIDS a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N15/87C12N15/867
CPCA61K48/00C12N15/86C12N2740/13043C12N2810/859C12N2810/10C12N2810/80C12N2810/851C12N2740/13045C12N15/87
Inventor UENO, MITSUHIROYOSHIOKA, HIROFUMIKONISHI, HARUKOHASHINO, KIMIKAZUMORISHITA, MIOCHONO, HIDETOMIYAMURA, TSUYOSHISANO, MUTSUMIASADA, KIYOZOFUJINAGA, KEIKATO, IKUNOSHIN
Owner TAKARA HOLDINGS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com